Skip to Main content Skip to Navigation
Journal articles

Potential of regulatory T cell-based therapies in the management of severe COVID-19

Abstract : In view of dysregulated immune response, cytokine storm and inflammation-induced severe lung damage in severely ill COVID-19 patients, we propose that CD4+CD25+FoxP3+ regulatory T cell-based therapies could be considered for the patient management
Complete list of metadatas

Cited literature [25 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02879881
Contributor : Bayry Jagadeesh <>
Submitted on : Wednesday, June 24, 2020 - 1:19:32 PM
Last modification on : Friday, September 18, 2020 - 2:35:08 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

Emmanuel Stephen-Victor, Mrinmoy Das, Anupama Karnam, Bruno Pitard, Jean-François Gautier, et al.. Potential of regulatory T cell-based therapies in the management of severe COVID-19. European Respiratory Journal, European Respiratory Society, 2020, ⟨10.1183/13993003.02182-2020⟩. ⟨inserm-02879881⟩

Share

Metrics

Record views

81


Données de recherche